{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T17:45:32Z","timestamp":1777311932829,"version":"3.51.4"},"reference-count":98,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T00:00:00Z","timestamp":1747094400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T00:00:00Z","timestamp":1747094400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100008793","name":"Universidad del Rosario","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008793","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Although some reports indicate ocular involvement in Inborn Errors of Immunity (IEI) patients, the characteristics of this association remain unclear. Increased awareness can facilitate early diagnosis and prevention of visual complications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To determine the prevalence and characterize ophthalmological manifestations in patients with IEI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A systematic literature search was performed across Embase, PubMed, and Lilacs. Observational studies with at least 10 IEI patients exhibiting ophthalmological manifestations were reviewed. A meta-analysis using a random effects model, weighted proportion, and 95% confidence intervals were reported as appropriate.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Sixty-two articles out of the 6,884 studies were included. The pooled prevalence of ocular manifestations in IEI patients was 54% (95%CI\u2009=\u200939\u201369), with a mean age of 11.1\u2009\u00b1\u20097.8 years and male predominance. Regarding the type of IEI with ocular involvement, the most frequently affected group was the Combined immunodeficiencies with associated or syndromic features (82%, 95%CI\u2009=\u200966\u201391), followed by the diseases of immune dysregulation (73%, 95%CI\u2009=\u200927\u201395), auto-inflammatory disorders (48%, 95%CI\u2009=\u200910\u201388), and congenital defects of phagocytes (39%, 95%CI\u2009=\u200911\u201376). Europe had the highest prevalence of patients with ocular manifestations (68%, 95%CI\u2009=\u200932\u201390). The most common ocular manifestations observed in IEI patients were those affecting ocular mobility, followed by those that involved the anterior segment, posterior segment, eyelids, and adnexal structures.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These results highlight a significant burden of ocular involvement in IEI patients, mainly during childhood and associated with amblyogenic factors. Therefore, ophthalmologists, pediatricians, and immunologists must be involved in early detection to prevent ocular complications and overall well-being.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10875-025-01880-4","type":"journal-article","created":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T04:01:59Z","timestamp":1747108919000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prevalence of Ophthalmological Manifestations in Patients with Inborn Errors of Immunity: A Systematic Review and Meta-Analysis"],"prefix":"10.1007","volume":"45","author":[{"given":"Laura","family":"Z\u00e1rate-Pinz\u00f3n","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1241-0715","authenticated-orcid":false,"given":"Germ\u00e1n","family":"Mej\u00eda-Salgado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Cifuentes-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6007-2821","authenticated-orcid":false,"given":"Oscar","family":"Correa-Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Amaris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0770-3943","authenticated-orcid":false,"given":"Alberto","family":"Alfaro-Murillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juanita","family":"T\u00e9llez-Zambrano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angie","family":"Verbel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Monje-Tobar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0684-1989","authenticated-orcid":false,"given":"Alejandra","family":"de-la-Torre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,13]]},"reference":[{"key":"1880_CR1","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jaut.2019.01.011","volume":"99","author":"L Amaya-Uribe","year":"2019","unstructured":"Amaya-Uribe L, Rojas M, Azizi G, Anaya J-M, Gershwin ME. Primary immunodeficiency and autoimmunity: A comprehensive review. J Autoimmun. 2019;99:52\u201372.","journal-title":"J Autoimmun"},{"key":"1880_CR2","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13223-018-0290-5","volume":"14","author":"C McCusker","year":"2018","unstructured":"McCusker C, Upton J, Warrington R. Primary immunodeficiency. Allergy Asthma Clin Immunol. 2018;14:61.","journal-title":"Allergy Asthma Clin Immunol"},{"key":"1880_CR3","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1007\/s10875-022-01352-z","volume":"42","author":"A Bousfiha","year":"2022","unstructured":"Bousfiha A, Moundir A, Tangye SG, Picard C, Jeddane L, Al-Herz W, et al. The 2022 update of IUIS phenotypical classification for human inborn errors of immunity. J Clin Immunol. 2022;42:1508\u201320.","journal-title":"J Clin Immunol"},{"key":"1880_CR4","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/nrrheum.2017.198","volume":"14","author":"RE Schmidt","year":"2018","unstructured":"Schmidt RE, Grimbacher B, Witte T. Autoimmunity and primary immunodeficiency: two sides of the same coin? Nat Rev Rheumatol. 2018;14:7\u201318.","journal-title":"Nat Rev Rheumatol"},{"key":"1880_CR5","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1007\/s12177-008-9010-6","volume":"1","author":"J Hori","year":"2008","unstructured":"Hori J. Mechanisms of immune privilege in the anterior segment of the eye: what we learn from corneal transplantation. J Ocul Biol Dis Inf. 2008;1:94\u2013100.","journal-title":"J Ocul Biol Dis Inf"},{"key":"1880_CR6","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1111\/j.1469-7580.2005.00394.x","volume":"206","author":"E Knop","year":"2005","unstructured":"Knop E, Knop N. The role of eye-associated lymphoid tissue in corneal immune protection. J Anat. 2005;206:271\u201385.","journal-title":"J Anat"},{"key":"1880_CR7","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1016\/j.jaip.2022.03.028","volume":"10","author":"MN Pham","year":"2022","unstructured":"Pham MN, Fuleihan RL, Sullivan KE, Cunningham-Rundles C. Ocular manifestations in primary immunodeficiency disorders: A report from the united States immunodeficiency network (USIDNET) registry. J Allergy Clin Immunology: Pract. 2022;10:1788\u201396.","journal-title":"J Allergy Clin Immunology: Pract"},{"key":"1880_CR8","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s10875-013-9974-2","volume":"34","author":"S Hosseinverdi","year":"2014","unstructured":"Hosseinverdi S, Hashemi H, Aghamohammadi A, Ochs HD, Rezaei N. Ocular involvement in primary immunodeficiency diseases. J Clin Immunol. 2014;34:23\u201338.","journal-title":"J Clin Immunol"},{"key":"1880_CR9","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1080\/1744666X.2021.1925543","volume":"17","author":"N Sharifinejad","year":"2021","unstructured":"Sharifinejad N, Zaki-Dizaji M, Tebyanian S, Zainaldain H, Jamee M, Rizvi FS, et al. Clinical, immunological, and genetic features in 938 patients with autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED): a systematic review. Expert Rev Clin Immunol. 2021;17:807\u201317.","journal-title":"Expert Rev Clin Immunol"},{"key":"1880_CR10","unstructured":"Clarity [Internet]. Clarity. [cited 2023 Oct 27]. Available from: https:\/\/www.clarityresearch.ca"},{"key":"1880_CR11","unstructured":"Tool to Assess Risk of Bias in. Case Control Studies [Internet]. DistillerSR. [cited 2023 Oct 27]. Available from: https:\/\/www.distillersr.com\/resources\/methodological-resources\/tool-to-assess-risk-of-bias-in-case-control-studies-distillersr"},{"key":"1880_CR12","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.jclinepi.2011.11.014","volume":"65","author":"D Hoy","year":"2012","unstructured":"Hoy D, Brooks P, Woolf A, Blyth F, March L, Bain C, et al. Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement. J Clin Epidemiol. 2012;65:934\u20139.","journal-title":"J Clin Epidemiol"},{"key":"1880_CR13","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1136\/bmjebm-2017-110853","volume":"23","author":"MH Murad","year":"2018","unstructured":"Murad MH, Sultan S, Haffar S, Bazerbachi F. Methodological quality and synthesis of case series and case reports. BMJ EBM. 2018;23:60\u20133.","journal-title":"BMJ EBM"},{"key":"1880_CR14","unstructured":"Risk of bias. tools - robvis (visualization tool) [Internet]. [cited 2023 Oct 27]. Available from: https:\/\/www.riskofbias.info\/welcome\/robvis-visualization-tool"},{"key":"1880_CR15","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JPT Higgins","year":"2003","unstructured":"Higgins JPT. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557\u201360.","journal-title":"BMJ"},{"key":"1880_CR16","doi-asserted-by":"crossref","unstructured":"Azizi G, Tavakol M, Yazdani R, Delavari S, Moeini Shad T, Rasouli SE et al. Autoimmune manifestations among 461 patients with monogenic inborn errors of immunity. Atanaskovic-Markovic M, editor. Pediatric Allergy Immunology. 2021;32:1335\u201348.","DOI":"10.1111\/pai.13510"},{"key":"1880_CR17","doi-asserted-by":"publisher","first-page":"e13010","DOI":"10.1111\/sji.13010","volume":"93","author":"RM Yadav","year":"2021","unstructured":"Yadav RM, Dalvi A, Gupta M, Bargir UA, Shabrish S, Aluri J, et al. Spectrum of inborn errors of immunity in a cohort of 90 patients presenting with complications to BCG vaccination in India. Scand J Immunol. 2021;93:e13010.","journal-title":"Scand J Immunol"},{"key":"1880_CR18","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.ejpn.2021.03.008","volume":"32","author":"J Bistritzer","year":"2021","unstructured":"Bistritzer J, Mijalovsky A, Nissenkorn A, Flusser H, Levy J, Nahum A, et al. Phenotypic variability in patients with unique double homozygous mutations causing variant ataxia telangiectasia. Eur J Pediatr Neurol. 2021;32:36\u20139.","journal-title":"Eur J Pediatr Neurol"},{"key":"1880_CR19","doi-asserted-by":"publisher","first-page":"623199","DOI":"10.3389\/fimmu.2020.623199","volume":"11","author":"N Al Sukaiti","year":"2021","unstructured":"Al Sukaiti N, Ahmed K, Alshekaili J, Al Kindi M, Cook MC, Farsi TA. A decade experience on severe combined immunodeficiency phenotype in Oman, bridging to newborn screening. Front Immunol. 2021;11:623199.","journal-title":"Front Immunol"},{"key":"1880_CR20","doi-asserted-by":"crossref","unstructured":"Ferre EMN, Rose SR, Rosenzweig SD, Burbelo PD, Romito KR, Niemela JE et al. Redefined clinical features and diagnostic criteria in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. JCI Insight [Internet]. 2016 [cited 2023 Oct 27];1. Available from: https:\/\/insight.jci.org\/articles\/view\/88782","DOI":"10.1172\/jci.insight.88782"},{"key":"1880_CR21","doi-asserted-by":"publisher","first-page":"12","DOI":"10.21911\/aai.545","volume":"19","author":"C Tunakan Dalgi\u00e7","year":"2021","unstructured":"Tunakan Dalgi\u00e7 C, Zerrin Sin A, Ardeniz F\u00d6. Retrospective analysis of autoimmune diseases and Immunologic characteristics of the adult primary immune deficiency cohort: 17 years experience of the tertiary referral immunology center in Turkey. Asthma Allergy Immunol. 2021;19:12\u201323.","journal-title":"Asthma Allergy Immunol"},{"key":"1880_CR22","doi-asserted-by":"publisher","first-page":"573","DOI":"10.31688\/ABMU.2020.55.4.03","volume":"55","author":"O Boyarchuk","year":"2020","unstructured":"Boyarchuk O, Kostyuchenko L, Volokha A, Bondarenko A, Hilfanova A, Boyko Y, et al. Clinical and immunological presentation of ataxia-telangiectasia. Arch Balk Med Union. 2020;55:573\u201381.","journal-title":"Arch Balk Med Union"},{"key":"1880_CR23","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/cei.13474","volume":"201","author":"T Barkai","year":"2020","unstructured":"Barkai T, Somech R, Broides A, Gavrieli R, Wolach B, Marcus N, et al. Late diagnosis of chronic granulomatous disease. Clin Exp Immunol. 2020;201:297\u2013305.","journal-title":"Clin Exp Immunol"},{"key":"1880_CR24","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.3389\/fimmu.2020.01119","volume":"11","author":"MJ Massaad","year":"2020","unstructured":"Massaad MJ, Zainal M, Al-Herz W. Frequency and manifestations of autoimmunity among children registered in the Kuwait National primary immunodeficiency registry. Front Immunol. 2020;11:1119.","journal-title":"Front Immunol"},{"key":"1880_CR25","doi-asserted-by":"publisher","first-page":"e12647","DOI":"10.1111\/sji.12647","volume":"87","author":"S Esenboga","year":"2018","unstructured":"Esenboga S, Cagdas D, Ozgur TT, Gur Cetinkaya P, Turkdemir LM, Sanal O, et al. Clinical and genetic features of the patients with X-Linked agammaglobulinemia from Turkey: Single\u2010centre experience. Scand J Immunol. 2018;87:e12647.","journal-title":"Scand J Immunol"},{"key":"1880_CR26","doi-asserted-by":"publisher","first-page":"026","DOI":"10.1055\/s-0037-1607216","volume":"49","author":"A Iodice","year":"2018","unstructured":"Iodice A, Galli J, Molinaro A, Franzoni A, Micheli R, Pinelli L, et al. Neurovisual assessment in children with ataxia telangiectasia. Neuropediatrics. 2018;49:026\u201334.","journal-title":"Neuropediatrics"},{"key":"1880_CR27","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s12519-017-0011-z","volume":"13","author":"H Akturk","year":"2017","unstructured":"Akturk H, Sutcu M, Somer A, Piskin S, Acar M, Ozmen M, et al. Ataxia telangiectasia in Turkey: multisystem involvement of 91 patients. World J Pediatr. 2017;13:465\u201371.","journal-title":"World J Pediatr"},{"key":"1880_CR28","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.jaci.2016.06.021","volume":"139","author":"TI Coulter","year":"2017","unstructured":"Coulter TI, Chandra A, Bacon CM, Babar J, Curtis J, Screaton N, et al. Clinical spectrum and features of activated phosphoinositide 3-kinase \u0394 syndrome: A large patient cohort study. J Allergy Clin Immunol. 2017;139:597\u2013e6064.","journal-title":"J Allergy Clin Immunol"},{"key":"1880_CR29","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1007\/s10875-016-0330-1","volume":"36","author":"\u0160 Blazina","year":"2016","unstructured":"Blazina \u0160, Markelj G, Jeverica AK, Toplak N, Bratani\u010d N, Jazbec J, et al. Autoimmune and inflammatory manifestations in 247 patients with primary Immunodeficiency\u2014a report from the Slovenian National registry. J Clin Immunol. 2016;36:764\u201373.","journal-title":"J Clin Immunol"},{"key":"1880_CR30","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1002\/art.39699","volume":"68","author":"S Nanthapisal","year":"2016","unstructured":"Nanthapisal S, Murphy C, Omoyinmi E, Hong Y, Standing A, Berg S, et al. Deficiency of adenosine deaminase type 2: A description of phenotype and genotype in fifteen cases. Arthritis Rheumatol. 2016;68:2314\u201322.","journal-title":"Arthritis Rheumatol"},{"key":"1880_CR31","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3109\/01658107.2015.1016579","volume":"39","author":"MS Salman","year":"2015","unstructured":"Salman MS, Chodirker BN. Neuro-Ophthalmological findings in children and adolescents with chronic ataxia. Neuro-Ophthalmology. 2015;39:125\u201331.","journal-title":"Neuro-Ophthalmology"},{"key":"1880_CR32","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/j.jaad.2012.12.950","volume":"68","author":"S Greenberger","year":"2013","unstructured":"Greenberger S, Berkun Y, Ben-Zeev B, Levi YB, Barziliai A, Nissenkorn A. Dermatologic manifestations of ataxia-telangiectasia syndrome. J Am Acad Dermatol. 2013;68:932\u20136.","journal-title":"J Am Acad Dermatol"},{"key":"1880_CR33","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ejmhg.2010.03.001","volume":"11","author":"AF Mohamed","year":"2010","unstructured":"Mohamed AF, El-Sayed NS, Seifeldin NS. Clinico-epidemiologic features of oculocutaneous albinism in Northeast section of Cairo\u2013 Egypt. Egypt J Med Hum Genet. 2010;11:167\u201372.","journal-title":"Egypt J Med Hum Genet"},{"key":"1880_CR34","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.ophtha.2009.08.023","volume":"117","author":"ET Tsilou","year":"2010","unstructured":"Tsilou ET, Giri N, Weinstein S, Mueller C, Savage SA, Alter BP. Ocular and orbital manifestations of the inherited bone marrow failure syndromes: Fanconi anemia and dyskeratosis congenita. Ophthalmology. 2010;117:615\u201322.","journal-title":"Ophthalmology"},{"key":"1880_CR35","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1136\/jnnp.2008.170522","volume":"80","author":"AG Shaikh","year":"2009","unstructured":"Shaikh AG, Marti S, Tarnutzer AA, Palla A, Crawford TO, Straumann D, et al. Gaze fixation deficits and their implication in ataxia-telangiectasia. J Neurol Neurosurg Psychiatry. 2009;80:858\u201364.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1880_CR36","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.pediatrneurol.2007.03.011","volume":"37","author":"Y Nofech-Mozes","year":"2007","unstructured":"Nofech-Mozes Y, Blaser SI, Kobayashi J, Grunebaum E, Roifman CM. Neurologic abnormalities in patients with adenosine deaminase deficiency. Pediatr Neurol. 2007;37:218\u201321.","journal-title":"Pediatr Neurol"},{"key":"1880_CR37","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.pediatrneurol.2007.03.002","volume":"37","author":"M Moin","year":"2007","unstructured":"Moin M, Aghamohammadi A, Kouhi A, Tavassoli S, Rezaei N, Ghaffari S-R, et al. Ataxia-Telangiectasia in Iran: clinical and laboratory features of 104 patients. Pediatr Neurol. 2007;37:21\u20138.","journal-title":"Pediatr Neurol"},{"key":"1880_CR38","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/01.md.0000229482.27398.ad","volume":"85","author":"JA Winkelstein","year":"2006","unstructured":"Winkelstein JA, Marino MC, Lederman HM, Jones SM, Sullivan K, Burks AW, et al. X-Linked agammaglobulinemia: report on a united States registry of 201 patients. Medicine. 2006;85:193\u2013202.","journal-title":"Medicine"},{"key":"1880_CR39","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/S0002-9394(02)01796-8","volume":"134","author":"AK Farr","year":"2002","unstructured":"Farr AK, Shalev B, Crawford TO, Lederman HM, Winkelstein JA, Repka MX. Ocular manifestations of ataxia-telangiectasia. Am J Ophthalmol. 2002;134:891\u20136.","journal-title":"Am J Ophthalmol"},{"key":"1880_CR40","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1002\/1096-8628(20010801)102:2<125::AID-AJMG1439>3.0.CO;2-0","volume":"102","author":"S Kivitie-Kallio","year":"2001","unstructured":"Kivitie-Kallio S, Norio R, Cohen, Syndrome. Essential features, natural history, and heterogeneity. Am J Med Genet. 2001;102:125\u201335.","journal-title":"Am J Med Genet"},{"key":"1880_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s004310050001","volume":"159","author":"CF Boerkoel","year":"2000","unstructured":"Boerkoel CF, O\u2019Neill S, Andr\u00e9 JL, Benke PJ, Bogdanov\u00ed\u0107 R, Bulla M, et al. Manifestations and treatment of Schimke immuno-osseous dysplasia: 14 new cases and a review of the literature. Eur J Pediatrics. 2000;159:1\u20137.","journal-title":"Eur J Pediatrics"},{"key":"1880_CR42","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1007\/BF02265285","volume":"88","author":"Y Ziv","year":"1992","unstructured":"Ziv Y, Frydman M, Lange E, Zelnik N, Rotman G, Julier C, et al. Ataxia-telangiectasia: linkage analysis in highly inbred Arab and Druze families and differentiation from an ataxia-microcephaly-cataract syndrome. Hum Genet. 1992;88:619\u201326.","journal-title":"Hum Genet"},{"key":"1880_CR43","unstructured":"Ataxia Telangiectasia in the British Isles: The Clinical and Laboratory Features of 70 Affected Individuals. QJM: An International Journal of Medicine [Internet]. 1992 [cited 2023 Oct 27]; Available from: https:\/\/academic.oup.com\/qjmed\/article\/82\/2\/169\/1524322\/Ataxia-Telangiectasia-in-the-British-Isles-The"},{"key":"1880_CR44","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1002\/ajmg.a.34226","volume":"155","author":"A Veerapandiyan","year":"2011","unstructured":"Veerapandiyan A, Abdul-Rahman OA, Adam MP, Lyons MJ, Manning M, Coleman K, et al. Chromosome 22q11.2 deletion syndrome in African\u2010American patients: A diagnostic challenge. Am J Med Genet Pt A. 2011;155:2186\u201395.","journal-title":"Am J Med Genet Pt A"},{"key":"1880_CR45","doi-asserted-by":"publisher","first-page":"33","DOI":"10.4103\/AOMD.AOMD_28_19","volume":"3","author":"M Mahadevappa","year":"2020","unstructured":"Mahadevappa M, Kamble N, Santhosh Kumar D, Yadav R, Netravathi M, Pal P. A clinical profile of 100 patients with ataxia telangiectasia seen at a tertiary care center. Ann Mov Disord. 2020;3:33.","journal-title":"Ann Mov Disord"},{"key":"1880_CR46","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/cei.13645","volume":"206","author":"I Yaz","year":"2021","unstructured":"Yaz I, Ozbek B, Bildik HN, Tan C, Oskay Halacli S, Soyak Aytekin E, et al. Clinical and laboratory findings in patients with leukocyte adhesion deficiency type I: A multicenter study in Turkey. Clin Exp Immunol. 2021;206:47\u201355.","journal-title":"Clin Exp Immunol"},{"key":"1880_CR47","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s10048-021-00639-4","volume":"22","author":"AS Shalash","year":"2021","unstructured":"Shalash AS, R\u00f6sler TW, Salama M, Pendziwiat M, M\u00fcller SH, Hopfner F, et al. Evidence for pathogenicity of variant ATM Val1729Leu in a family with ataxia telangiectasia. Neurogenetics. 2021;22:143\u20137.","journal-title":"Neurogenetics"},{"key":"1880_CR48","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1080\/09273948.2021.1995762","volume":"31","author":"J Luo","year":"2023","unstructured":"Luo J, Peng J, Zhao P-Q, Fei P. CMV retinitis in Wiskott Aldrich syndrome. Ocul Immunol Inflamm. 2023;31:134\u201341.","journal-title":"Ocul Immunol Inflamm"},{"key":"1880_CR49","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1002\/ajmg.a.61829","volume":"182","author":"R Al-Sulaiman","year":"2020","unstructured":"Al-Sulaiman R, Othman A, El\u2010Akouri K, Fareed S, AlMulla H, Sukik A, et al. A founder RAB27A variant causes griscelli syndrome type 2 with phenotypic heterogeneity in Qatari families. Am J Med Genet Pt A. 2020;182:2570\u201380.","journal-title":"Am J Med Genet Pt A"},{"key":"1880_CR50","doi-asserted-by":"publisher","first-page":"100133","DOI":"10.1016\/j.waojou.2020.100133","volume":"13","author":"S Qureshi","year":"2020","unstructured":"Qureshi S, Mir F, Junejo S, Saleem K, Zaidi S, Naveed AB, et al. The spectrum of primary immunodeficiencies at a tertiary care hospital in Pakistan. World Allergy Organ J. 2020;13:100133.","journal-title":"World Allergy Organ J"},{"key":"1880_CR51","doi-asserted-by":"publisher","first-page":"86","DOI":"10.4103\/jpn.JPN_145_18","volume":"15","author":"F Incecik","year":"2020","unstructured":"Incecik F, Herguner O, Mungan N. Clinical features and molecular genetics of autosomal recessive ataxia in the Turkish population. J Pediatr Neurosci. 2020;15:86.","journal-title":"J Pediatr Neurosci"},{"key":"1880_CR52","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.aller.2019.04.010","volume":"47","author":"IM Carneiro","year":"2019","unstructured":"Carneiro IM, Rodrigues A, Pinho L, De Jesus Nunes-Santos C, De Barros Dorna M, Moschione Castro APB, et al. Chediak\u2013Higashi syndrome: lessons from a single-centre case series. Allergol Immunopathol. 2019;47:598\u2013603.","journal-title":"Allergol Immunopathol"},{"key":"1880_CR53","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1093\/rheumatology\/key445","volume":"58","author":"C Papadopoulou","year":"2019","unstructured":"Papadopoulou C, Omoyinmi E, Standing A, Pain CE, Booth C, D\u2019Arco F, et al. Monogenic mimics of Beh\u00e7et\u2019s disease in the young. Rheumatology. 2019;58:1227\u201338.","journal-title":"Rheumatology"},{"key":"1880_CR54","first-page":"67","volume":"27","author":"T Patiroglu","year":"2016","unstructured":"Patiroglu T, Akar HH, Unal E, Chiang SC, Schlums H, Tesi B, et al. PARTIAL OCULOCUTANEOUS ALBINISM AND IMMUNODEFICIENCY SYNDROMES: TEN YEARS EXPERIENCE FROM A SINGLE CENTER IN TURKEY. Genet Couns. 2016;27:67\u201376.","journal-title":"Genet Couns"},{"key":"1880_CR55","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1002\/pbc.24637","volume":"60","author":"K Nagai","year":"2013","unstructured":"Nagai K, Ochi F, Terui K, Maeda M, Ohga S, Kanegane H, et al. Clinical characteristics and outcomes of ch\u00e9diak\u2013Higashi syndrome: A nationwide survey of Japan. Pediatr Blood Cancer. 2013;60:1582\u20136.","journal-title":"Pediatr Blood Cancer"},{"key":"1880_CR56","doi-asserted-by":"publisher","first-page":"367","DOI":"10.5114\/ceji.2013.37748","volume":"3","author":"M Pac","year":"2013","unstructured":"Pac M, Miko\u0142u\u0107 B, Pietrucha B, Wolska-Ku\u015bnierz B, Pi\u0105tosa B, Micha\u0142kiewicz J, et al. Clinical and immunological analysis of patients with X-linked agammaglobulinemia\u2013 single center experience. Cejoi. 2013;3:367\u201371.","journal-title":"Cejoi"},{"key":"1880_CR57","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.jaapos.2007.09.016","volume":"12","author":"AO Khan","year":"2008","unstructured":"Khan AO, Oystreck DT, Koenig M, Salih MA. Ophthalmic features of ataxia telangiectasia\u2013like disorder. J Am Association Pediatr Ophthalmol Strabismus. 2008;12:186\u20139.","journal-title":"J Am Association Pediatr Ophthalmol Strabismus"},{"key":"1880_CR58","first-page":"557","volume":"85","author":"R Riise","year":"2007","unstructured":"Riise R, Ygge J, Lindman C, Stray-Pedersen A, Bek T, R\u00f8dningen OK, et al. Ocular findings in Norwegian patients with ataxia\u2010telangiectasia: a 5 year prospective cohort study. Acta Ophthalmol Scand. 2007;85:557\u201362.","journal-title":"Acta Ophthalmol Scand"},{"key":"1880_CR59","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1097\/01.mph.0000172280.27318.80","volume":"27","author":"N Rezaei","year":"2005","unstructured":"Rezaei N, Farhoudi A, Ramyar A, Pourpak Z, Aghamohammadi A, Mohammadpour B, et al. Congenital neutropenia and primary immunodeficiency disorders: A survey of 26 Iranian patients. J Pediatr Hematol Oncol. 2005;27:351\u20136.","journal-title":"J Pediatr Hematol Oncol"},{"key":"1880_CR60","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/S0022-3476(99)70207-6","volume":"134","author":"H Kawame","year":"1999","unstructured":"Kawame H, Hannibal MC, Hudgins L, Pagon RA. Phenotypic spectrum and management issues in Kabuki syndrome. J Pediatr. 1999;134:480\u20135.","journal-title":"J Pediatr"},{"key":"1880_CR61","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/1531-8249(199909)46:3<287::AID-ANA3>3.0.CO;2-0","volume":"46","author":"RF Lewis","year":"1999","unstructured":"Lewis RF, Lederman HM, Crawford TO. Ocular motor abnormalities in ataxia telangiectasia. Ann Neurol. 1999;46:287\u201395.","journal-title":"Ann Neurol"},{"key":"1880_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/brain\/119.1.1","volume":"119","author":"P Rudge","year":"1996","unstructured":"Rudge P, Webster ADB, Revesz T, Warner T, Espanol T, Cunningham-Rundles C, et al. Encephalomyelitis in primary hypogammaglobulinaemia. Brain. 1996;119:1\u201315.","journal-title":"Brain"},{"key":"1880_CR63","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/0002-9394(83)90377-X","volume":"95","author":"AG Palestine","year":"1983","unstructured":"Palestine AG, Meyers SM, Fauci AS, Gallin JI. Ocular findings in patients with neutrophil dysfunction. Am J Ophthalmol. 1983;95:598\u2013604.","journal-title":"Am J Ophthalmol"},{"key":"1880_CR64","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/S0002-9394(02)01709-9","volume":"134","author":"PA Latkany","year":"2002","unstructured":"Latkany PA, Jabs DA, Smith JR, Rosenbaum JT, Tessler H, Schwab IR, et al. Multifocal choroiditis in patients with Familial juvenile systemic granulomatosis. Am J Ophthalmol. 2002;134:897\u2013904.","journal-title":"Am J Ophthalmol"},{"key":"1880_CR65","first-page":"682","volume":"22","author":"S Alyasin","year":"2019","unstructured":"Alyasin S, Esmaeilzadeh H, Ebrahimi N, Nabavizadeh SH, Nemati H. Clinical presentation of Ataxia-Telangiectasia. Arch Iran Med. 2019;22:682\u20136.","journal-title":"Arch Iran Med"},{"key":"1880_CR66","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/S0190-9622(84)80089-4","volume":"10","author":"LE Cohen","year":"1984","unstructured":"Cohen LE, Tanner DJ, Schaefer HG, Levis WR. Common and uncommon cutaneous findings in patients with ataxia-telangiectasia. J Am Acad Dermatol. 1984;10:431\u20138.","journal-title":"J Am Acad Dermatol"},{"key":"1880_CR67","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1097\/00004728-199409000-00008","volume":"18","author":"L Farina","year":"1994","unstructured":"Farina L, Uggetti C, Ottolini A, Martelli A, Bergamaschi R, Sibilla L, et al. Ataxia-telangiectasia: MR and CT findings. J Comput Assist Tomogr. 1994;18:724\u20137.","journal-title":"J Comput Assist Tomogr"},{"key":"1880_CR68","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1136\/bjo.52.3.217","volume":"52","author":"B Jay","year":"1968","unstructured":"Jay B, Blach RK, Wells RS. Ocular manifestations of ichthyosis. Br J Ophthalmol. 1968;52:217\u201326.","journal-title":"Br J Ophthalmol"},{"key":"1880_CR69","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1097\/00006982-200306000-00012","volume":"23","author":"S-J Kim","year":"2003","unstructured":"Kim S-J, Kim JG, Yu YS. CHORIORETINAL LESIONS IN PATIENTS WITH CHRONIC GRANULOMATOUS DISEASE. Retina. 2003;23:360\u20135.","journal-title":"Retina"},{"key":"1880_CR70","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.ophtha.2022.10.026","volume":"130","author":"LA Huryn","year":"2023","unstructured":"Huryn LA, Kozycki CT, Serpen JY, Zein WM, Ullah E, Iannaccone A, et al. Ophthalmic manifestations of ROSAH (Retinal dystrophy, optic nerve edema, splenomegaly, anhidrosis, and Headache) syndrome, an inherited NF \u03baB\u2013Mediated autoinflammatory disease with retinal dystrophy. Ophthalmology. 2023;130:423\u201332.","journal-title":"Ophthalmology"},{"key":"1880_CR71","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.3389\/fimmu.2020.02001","volume":"11","author":"Y-H Yeh","year":"2020","unstructured":"Yeh Y-H, Hsieh M-Y, Lee W-I, Huang J-L, Chen L-C, Yeh K-W, et al. Distinct clinical features and novel mutations in Taiwanese patients with X-Linked agammaglobulinemia. Front Immunol. 2020;11:2001.","journal-title":"Front Immunol"},{"key":"1880_CR72","doi-asserted-by":"publisher","first-page":"15284","DOI":"10.1038\/s41598-017-15127-9","volume":"7","author":"LL Mariani","year":"2017","unstructured":"Mariani LL, Rivaud-P\u00e9choux S, Charles P, Ewenczyk C, Meneret A, Monga BB, et al. Comparing ataxias with oculomotor apraxia: a multimodal study of AOA1, AOA2 and AT focusing on video-oculography and alpha-fetoprotein. Sci Rep. 2017;7:15284.","journal-title":"Sci Rep"},{"key":"1880_CR73","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1212\/WNL.0000000000000794","volume":"83","author":"A Meneret","year":"2014","unstructured":"Meneret A, Ahmar-Beaugendre Y, Rieunier G, Mahlaoui N, Gaymard B, Apartis E, et al. The pleiotropic movement disorders phenotype of adult ataxia-telangiectasia. Neurology. 2014;83:1087\u201395.","journal-title":"Neurology"},{"key":"1880_CR74","doi-asserted-by":"publisher","first-page":"3034","DOI":"10.1152\/jn.00721.2010","volume":"105","author":"AG Shaikh","year":"2011","unstructured":"Shaikh AG, Marti S, Tarnutzer AA, Palla A, Crawford TO, Straumann D, et al. Ataxia telangiectasia: a disease model to understand the cerebellar control of vestibular reflexes. J Neurophysiol. 2011;105:3034\u201341.","journal-title":"J Neurophysiol"},{"key":"1880_CR75","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/S0022-3476(99)70299-4","volume":"134","author":"D Goldblatt","year":"1999","unstructured":"Goldblatt D, Butcher J, Thrasher AJ, Russell-Eggitt I. Chorioretinal lesions in patients and carriers of chronic granulomatous disease. J Pediatr. 1999;134:780\u20133.","journal-title":"J Pediatr"},{"key":"1880_CR76","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.jaapos.2009.05.011","volume":"13","author":"S Al-Muhsen","year":"2009","unstructured":"Al-Muhsen S, Al-Hemidan A, Al-Shehri A, Al-Harbi A, Al-Ghonaium A, Al-Saud B, et al. Ocular manifestations in chronic granulomatous disease in Saudi Arabia. J Am Association Pediatr Ophthalmol Strabismus. 2009;13:396\u20139.","journal-title":"J Am Association Pediatr Ophthalmol Strabismus"},{"key":"1880_CR77","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1080\/1744666X.2021.1850272","volume":"16","author":"FS Rizvi","year":"2020","unstructured":"Rizvi FS, Zainaldain H, Rafiemanesh H, Jamee M, Hossein-Khannazer N, Hamedifar H, et al. Autoimmunity in common variable immunodeficiency: a systematic review and meta-analysis. Expert Rev Clin Immunol. 2020;16:1227\u201335.","journal-title":"Expert Rev Clin Immunol"},{"key":"1880_CR78","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/ppul.24599","volume":"55","author":"N Ramzi","year":"2020","unstructured":"Ramzi N, Jamee M, Bakhtiyari M, Rafiemanesh H, Zainaldain H, Tavakol M, et al. Bronchiectasis in common variable immunodeficiency: A systematic review and meta-analysis. Pediatr Pulmonol. 2020;55:292\u20139.","journal-title":"Pediatr Pulmonol"},{"key":"1880_CR79","doi-asserted-by":"publisher","first-page":"e833","DOI":"10.1002\/iid3.833","volume":"11","author":"F Mohammadi","year":"2023","unstructured":"Mohammadi F, Yadegar A, Mardani M, Ayati A, Abolhassani H, Rezaei N. Organ-based clues for diagnosis of inborn errors of immunity: A practical guide for clinicians. Immun Inflam Disease. 2023;11:e833.","journal-title":"Immun Inflam Disease"},{"key":"1880_CR80","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/j.jaci.2021.04.015","volume":"148","author":"J Thalhammer","year":"2021","unstructured":"Thalhammer J, Kindle G, Nieters A, Rusch S, Sepp\u00e4nen MRJ, Fischer A, et al. Initial presenting manifestations in 16,486 patients with inborn errors of immunity include infections and noninfectious manifestations. J Allergy Clin Immunol. 2021;148:1332\u2013e13415.","journal-title":"J Allergy Clin Immunol"},{"key":"1880_CR81","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1007\/s12026-014-8498-z","volume":"60","author":"V Modell","year":"2014","unstructured":"Modell V, Knaus M, Modell F, Roifman C, Orange J, Notarangelo LD. Global overview of primary immunodeficiencies: a report from Jeffrey modell centers worldwide focused on diagnosis, treatment, and discovery. Immunol Res. 2014;60:132\u201344.","journal-title":"Immunol Res"},{"key":"1880_CR82","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.jaci.2020.08.022","volume":"147","author":"CD Platt","year":"2021","unstructured":"Platt CD, Zaman F, Bainter W, Stafstrom K, Almutairi A, Reigle M, et al. Efficacy and economics of targeted panel versus whole-exome sequencing in 878 patients with suspected primary immunodeficiency. J Allergy Clin Immunol. 2021;147:723\u20136.","journal-title":"J Allergy Clin Immunol"},{"key":"1880_CR83","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/cei.12172","volume":"175","author":"JDM Edgar","year":"2013","unstructured":"Edgar JDM, Buckland M, Guzman D, Conlon NP, Knerr V, Bangs C, et al. The united Kingdom primary immune deficiency (UKPID) registry: report of the first 4 years\u2019 activity 2008\u20132012. Clin Exp Immunol. 2013;175:68\u201378.","journal-title":"Clin Exp Immunol"},{"key":"1880_CR84","doi-asserted-by":"crossref","unstructured":"Garcia Torres DA, Mac\u00edas-Robles AP, P\u00e9rez-Jim\u00e9nez L, Rodr\u00edguez-Salda\u00f1a MB, Albores-Ch\u00e1vez YF, Tlacuilo-Parra A et al. Caracter\u00edsticas cl\u00ednicas de las inmunodeficiencias primarias en ni\u00f1os de un hospital de tercer nivel. RAM [Internet]. 2021 [cited 2023 Oct 27];67. Available from: https:\/\/revistaalergia.mx\/ojs\/index.php\/ram\/article\/view\/721","DOI":"10.29262\/ram.v67i3.721"},{"key":"1880_CR85","doi-asserted-by":"publisher","first-page":"78","DOI":"10.2500\/aap.2021.42.200113","volume":"42","author":"M Dilley","year":"2021","unstructured":"Dilley M, Wangberg H, Noone J, Geng B. Primary immunodeficiency diseases treated with Immunoglobulin and associated comorbidities. Allergy Asthma Proc. 2021;42:78\u201386.","journal-title":"Allergy Asthma Proc"},{"key":"1880_CR86","doi-asserted-by":"publisher","unstructured":"Hamm LM, Black J, Dai S, Thompson B. Global processing in amblyopia: a review. Front Psychol [Internet]. 2014 [cited 2023 Oct 27];5. Available from: http:\/\/journal.frontiersin.org\/article\/https:\/\/doi.org\/10.3389\/fpsyg.2014.00583\/abstract","DOI":"10.3389\/fpsyg.2014.00583\/abstract"},{"key":"1880_CR87","unstructured":"Akalu YT, Bogunovic D. Inborn errors of immunity: an expanding universe of disease and genetic architecture. Nat Rev Genet [Internet]. 2023 [cited 2023 Nov 15]; Available from: https:\/\/www.nature.com\/articles\/s41576-023-00656-z"},{"key":"1880_CR88","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s12026-023-09391-3","volume":"71","author":"IV Venkatachari","year":"2023","unstructured":"Venkatachari IV, Chougule A, Gowri V, Taur P, Bodhanwala M, Prabhu S, et al. Monogenic inborn errors of immunity in autoimmune disorders. Immunol Res. 2023;71:771\u201380.","journal-title":"Immunol Res"},{"key":"1880_CR89","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s13023-016-0543-7","volume":"11","author":"C Rothblum-Oviatt","year":"2016","unstructured":"Rothblum-Oviatt C, Wright J, Lefton-Greif MA, McGrath-Morrow SA, Crawford TO, Lederman HM. Ataxia telangiectasia: a review. Orphanet J Rare Dis. 2016;11:159.","journal-title":"Orphanet J Rare Dis"},{"key":"1880_CR90","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/pai.13020","volume":"30","author":"P Amirifar","year":"2019","unstructured":"Amirifar P, Ranjouri MR, Yazdani R, Abolhassani H, Aghamohammadi A. Ataxia-telangiectasia: A review of clinical features and molecular pathology. Pediatr Allergy Immunol. 2019;30:277\u201388.","journal-title":"Pediatr Allergy Immunol"},{"key":"1880_CR91","unstructured":"ESID - European Society for Immunodeficiencies [Internet]. [cited 2023 Oct 27]. Available from: https:\/\/www.esid.org\/Education\/Ataxia-Telangiectasia"},{"key":"1880_CR92","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1007\/s10875-014-0028-1","volume":"34","author":"KE Sullivan","year":"2014","unstructured":"Sullivan KE, Puck JM, Notarangelo LD, Fuleihan R, Caulder T, Wang C, et al. USIDNET: A strategy to build a community of clinical immunologists. J Clin Immunol. 2014;34:428\u201335.","journal-title":"J Clin Immunol"},{"key":"1880_CR93","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/cei.12496","volume":"178","author":"B Grimbacher","year":"2014","unstructured":"Grimbacher B, ESID Registry Working Party. The European society for immunodeficiencies (ESID) registry 2014: the ESID registry 2014. Clin Exp Immunol. 2014;178:18\u201320.","journal-title":"Clin Exp Immunol"},{"key":"1880_CR94","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s10875-006-9052-0","volume":"27","author":"LE Leiva","year":"2007","unstructured":"Leiva LE, Zelazco M, Oleastro M, Carneiro-Sampaio M, Condino-Neto A, Costa-Carvalho BT, et al. Primary immunodeficiency diseases in Latin America: the second report of the LAGID registry. J Clin Immunol. 2007;27:101\u20138.","journal-title":"J Clin Immunol"},{"key":"1880_CR95","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1097\/j.pain.0000000000000314","volume":"157","author":"KE Mansfield","year":"2016","unstructured":"Mansfield KE, Sim J, Jordan JL, Jordan KP. A systematic review and meta-analysis of the prevalence of chronic widespread pain in the general population. Pain. 2016;157:55\u201364.","journal-title":"Pain"},{"key":"1880_CR96","doi-asserted-by":"publisher","first-page":"e00716","DOI":"10.1016\/j.heliyon.2018.e00716","volume":"4","author":"A Assefa","year":"2018","unstructured":"Assefa A, Bihon A. A systematic review and meta-analysis of prevalence of Escherichia coli in foods of animal origin in Ethiopia. Heliyon. 2018;4:e00716.","journal-title":"Heliyon"},{"key":"1880_CR97","doi-asserted-by":"crossref","unstructured":"Bacigalupo I, Mayer F, Lacorte E, Di Pucchio A, Marzolini F, Canevelli M et al. A Systematic Review and Meta-Analysis on the Prevalence of Dementia in Europe: Estimates from the Highest-Quality Studies Adopting the DSM IV Diagnostic Criteria. Bruni AC, editor. JAD. 2018;66:1471\u201381.","DOI":"10.3233\/JAD-180416"},{"key":"1880_CR98","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1111\/apt.15231","volume":"49","author":"P Navarro","year":"2019","unstructured":"Navarro P, Arias \u00c1, Arias-Gonz\u00e1lez L, Laserna\u2010Mendieta EJ, Ruiz\u2010Ponce M, Lucendo AJ. Systematic review with meta\u2010analysis: the growing incidence and prevalence of eosinophilic oesophagitis in children and adults in population\u2010based studies. Aliment Pharmacol Ther. 2019;49:1116\u201325.","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-025-01880-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-025-01880-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-025-01880-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T17:02:10Z","timestamp":1777309330000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-025-01880-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,13]]},"references-count":98,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1880"],"URL":"https:\/\/doi.org\/10.1007\/s10875-025-01880-4","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,13]]},"assertion":[{"value":"13 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"OCJ reports receiving speaker fees from Sanofi, Takeda, Bussi\u00e9, Axon-Pharma, and Pint-Pharma; Support for attending meetings and travel from GSK, Sanofi, and Takeda; currently receives honoraria for research activities from AstraZeneca paid to his institution; additionally, was an employee of Takeda before the execution of this study. The other authors reported no potential conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"92"}}